Inspections, Compliance, Enforcement, and Criminal Investigations
Sybron Dental Specialties, Inc.- Close Out Letter 10/2/12
| Public Health Service Food and Drug Administration |
10903 New Hampshire Avenue |
OCT 2, 2012
Mr. Vicente Reynal
President, Ormco Corporation
1717 West Collins Avenue
Orange, California 92867
Dear Mr. Reynal:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter (Warning Letter No. 313518), dated July 17, 2012. Based on our evaluation, it appears that your firm has addressed the violation contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your firm's state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely yours,
/S/
Steven D. Silverman
Director
Office of Compliance
Center for Devices and
Radiological Health
cc:
Ms. Colleen Boswell
VP, Regulatory Affairs
Sybron Dental Specialties, Inc.
1717 West Collins Avenue
Orange, California 92867





Department of Health and Human Services

